Authors
Latest:
Exenatide for Parkinson Symptoms: Early Results Are PositiveExenatide, a GLP-1 agonist, has been shown to protect neurons. The authors of two small studies of this agent's effects on motor function in Parkinson disease discuss the evidence here.
Latest:
Dietary Therapy to Improve Epilepsy Outcomes: Case VignettesThe authors present illustrative fictional accounts of patients with medical problems with co-occurring epilepsy.
Latest:
Dietary Therapy to Improve Epilepsy Outcomes: Case VignettesThe authors present illustrative fictional accounts of patients with medical problems with co-occurring epilepsy.
Latest:
Case Study: Siblings With Hypotonia in All LimbsTwo young siblings presented to the pediatric department with mental retardation, developmental delay, ataxia, and nystagmus since birth. What's your diagnosis after reviewing the case?
Latest:
Eight Key Features of Post-Concussion CareIt is often unclear which treatments are most appropriate for the constellation of concussion symptoms. Thus, evidence-based education as well as treatment and management options to facilitate recovery are required.
Latest:
6 Essential Nutrition Recommendations for Parkinson DiseaseThis article provides some straightforward nutritional recommendations that neurologists can share with their patients.
Latest:
The Gut Has It: Microbes and ParkinsonWhile it is premature to conclude that changes in intestinal microbes influence the genesis or progression of PD, preliminary evidence indicates that they may be associated with inflammation in the intestinal wall.
Latest:
Top Issues in Emergency Neurology TodayNeurology on the front lines engages patients and their families in a shared decision-making process regarding goals of care.
Latest:
Neurocognitive Outcomes in Primary CNS Lymphoma: Clinical ImplicationsPrimary central nervous system lymphoma (PCNSL) is a rare but aggressive malignancy that accounts for approximately 3% of all primary CNS cancer. New studies have changed the landscape of PCNSL treatment paradigms and expectations for outcome.
Latest:
Neurocognitive Outcomes in Primary CNS Lymphoma: Clinical ImplicationsPrimary central nervous system lymphoma (PCNSL) is a rare but aggressive malignancy that accounts for approximately 3% of all primary CNS cancer. New studies have changed the landscape of PCNSL treatment paradigms and expectations for outcome.
Latest:
Treating Menstrual MigrainesGiven the severity and treatment resistance of menstrual migraine, clinicians should watch for the signs and symptoms discussed in this case.
Latest:
Treating Menstrual MigrainesGiven the severity and treatment resistance of menstrual migraine, clinicians should watch for the signs and symptoms discussed in this case.
Latest:
Differential Diagnosis of Meningitis and EncephalitisThe authors distinguish between the clinical entities of meningitis, encephalitis, and encephalopathy.
Latest:
Differential Diagnosis of Meningitis and EncephalitisThe authors distinguish between the clinical entities of meningitis, encephalitis, and encephalopathy.
Latest:
Thrown Around by the DevilFor the past year, a patient lived in such utter fear of her symptoms that she became housebound.
Latest:
Mini Quiz: Deep Brain Stimulation for Memory ImpairmentWhich brain regions are potential deep brain stimulation targets for neurological disorders with memory impairment? Take the quiz and learn more.
Latest:
Sleep Deprivation Among Frontline Health Care Workers During COVID-19 Turns CriticalThe pandemic's impact stretches across all aspects of life, and has particularly concerning effects on the sleep of those working on the frontlines providing care of patients.
Latest:
Addressing Behavioral Health Issues in Pediatric EpilepsyThe highest level of comprehensive care targets youths with epilepsy who have known comorbid psychiatric, developmental, and cognitive disorders and/or a history of nonadherence to seizure medication.
Latest:
Addressing Behavioral Health Issues in Pediatric EpilepsyThe highest level of comprehensive care targets youths with epilepsy who have known comorbid psychiatric, developmental, and cognitive disorders and/or a history of nonadherence to seizure medication.
Latest:
A Case of Cerebral Amyloid Angiopathy-Related Inflammation With Pathologic FeaturesA 71-year-old woman presented to the emergency department with subacute headaches and altered behavior that was initially attributed to emotional distress. What did the tests show?
Latest:
A Case of Cerebral Amyloid Angiopathy-Related Inflammation With Pathologic FeaturesA 71-year-old woman presented to the emergency department with subacute headaches and altered behavior that was initially attributed to emotional distress. What did the tests show?
Latest:
The Next Wave of Stroke Care Beyond the Acute Phase: Matthew Schrag, MD, PhDThe associate professor of neurology at Vanderbilt University Medical Center discussed exploring promising opportunities in other phases outside of the acute phase of ischemic stroke. [WATCH TIME: 3 minutes]
Latest:
A Clinical Update of Intracerebral HemorrhageA summary of current treatment guidelines, application, and emerging developments in the area of spontaneous nontraumatic ICH.
Latest:
A Clinical Update of Intracerebral HemorrhageA summary of current treatment guidelines, application, and emerging developments in the area of spontaneous nontraumatic ICH.
Latest:
A Case of PML-IRIS: Diagnostic and Treatment ConsiderationsOn the challenges of treating progressive multifocal leukoencephalopathy in MS patients.
Latest:
A Case of PML-IRIS: Diagnostic and Treatment ConsiderationsOn the challenges of treating progressive multifocal leukoencephalopathy in MS patients.
Latest:
Diagnosing and Treating MELAS: Issues for CliniciansDifferential diagnosis and treatment of mitochondrial encephalomyopathy lactic acidosis and stroke-like syndrome.
Latest:
Diagnosing and Treating MELAS: Issues for CliniciansDifferential diagnosis and treatment of mitochondrial encephalomyopathy lactic acidosis and stroke-like syndrome.
Latest:
Saliva: A New Tool for Concussion Diagnosis?Recognizing the need for objective markers of brain injury, researchers have dedicated extensive efforts to developing concussion biomarkers.
Latest:
Updates on the Diagnostics Accelerator, Future Goals of the ADDF: Howard Fillit, MDThe founding executive director of the Alzheimer’s Drug Discovery Foundation commented on ongoing developments from the organization, particularly the diagnostics accelerator, which aims at identifying a better way to diagnose Alzheimer disease. [WATCH TIME: 6 minutes]
